SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001558370-23-005460
Filing Date
2023-04-05
Accepted
2023-04-05 07:35:53
Documents
12
Period of Report
2023-03-31
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K gbio-20230331x8k.htm   iXBRL 8-K 33328
  Complete submission text file 0001558370-23-005460.txt   136361

Data Files

Seq Description Document Type Size
2 EX-101.SCH gbio-20230331.xsd EX-101.SCH 3110
3 EX-101.LAB gbio-20230331_lab.xml EX-101.LAB 11023
4 EX-101.PRE gbio-20230331_pre.xml EX-101.PRE 9467
6 EXTRACTED XBRL INSTANCE DOCUMENT gbio-20230331x8k_htm.xml XML 4114
Mailing Address 301 BINNEY STREET CAMBRIDGE MA 02142
Business Address 301 BINNEY STREET CAMBRIDGE MA 02142 857-529-5908
Generation Bio Co. (Filer) CIK: 0001733294 (see all company filings)

IRS No.: 814301281 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39319 | Film No.: 23801187
SIC: 2834 Pharmaceutical Preparations